Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC20334 | CDK2 inhibitor 73 Featured |
CDK2 inhibitor 73 is a potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM)..
More description
|
![]() |
DC40786 | (S,R,S)-AHPC-C6-NH2 hydrochloride Featured |
(S,R,S)-AHPC-C6-NH2 hydrochloride (VH032-C6-NH2 hydrochloride) is a synthesized?E3 ligase ligand-linker conjugate?that incorporates the VH032 based VHL ligand and a linker used for AKT PROTAC degrader. (S,R,S)-AHPC-C6-NH2 hydrochloride is XF038-161A, example 6, extracted from patent WO2019173516A1.
More description
|
![]() |
DC7080 | BAM 7 Featured |
BAM 7 is a direct and selective activator of proapoptotic Bax with EC50 of 3.3 μM.
More description
|
![]() |
DC23979 | BAMB-4(ITPKA-IN-C14) Featured |
A specific and membrane-permeable inhibitor of the InsP3Kinase activity of ITPKA (inositol-1,4,5-trisphosphate-3-kinase A) with IC50 of 20 uM.
More description
|
![]() |
DC8203 | b-AP15(NSC687852) Featured |
b-AP15(NSC687852) is a specific inhibitor of the deubiquitinating enzymes UCHL5 and Usp14 of the 26S proteasome. It blocks the deubiquitinating activity of the 26S proteasome.
More description
|
![]() |
DC20759 | BCI-215 Featured |
BCI-215 (BCI215) is a potent, tumor cell-selective dual specificity MAPK phosphatase (DUSP-MKP) inhibitor.
More description
|
![]() |
DC7622 | BIBX1382 Featured |
BIBX 1382 is a potent, selective inhibitor of EGFR tyrosine kinase (IC50 = 3 nM); displays > 1000-fold lower potency against ErbB2 (IC50 = 3.4 μM) and a range of other related tyrosine kinases (IC50 > 10 μM).
More description
|
![]() |
DC22602 | Brivanib alaninate(BMS-582664) Featured |
A prodrug of Brivanib, which is a dual inhibitor of VEGFR2 and FGFR1 with IC50 of 25 nM and 148 nM respectively.
More description
|
![]() |
DC24037 | CaMKII-IN-1 Featured |
A potent and highly selective CaMKII inhibitor with IC50 of 63 nM.
More description
|
![]() |
DC7591 | CAY10650 Featured |
CAY10650 is a highly potent (IC50 = 12 nM) cPLA2α inhibitor.
More description
|
![]() |
DC24106 | CPDA Featured |
A potent SHIP2 inhibitor that enhances in vitro insulin signaling through the Akt pathway more efficiently than AS1949490, and ameliorates abnormal glucose metabolism in diabetic (db/db) mice.
More description
|
![]() |
DC11393 | CDM-NAG Featured |
CDM-NAG is a useful tool compound to deliver the siRNA.
More description
|
![]() |
DC8138 | CEP-28122 Featured |
CEP-28122 is a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.
More description
|
![]() |
DC8196 | CEP-32496 Featured |
CEP-32496 is a highly potent inhibitor of BRAF(V600E/WT) and c-Raf with Kd of 14 nM/36 nM and 39 nM, also potent to Abl-1, c-Kit, Ret, PDGFRβ and VEGFR2, respectively; insignificant affinity for MEK-1, MEK-2, ERK-1 and ERK-2.
More description
|
![]() |
DC8009 | CEP-37440 Featured |
CEP-37440 is a novel potent and selective Dual FAK/ALK inhibitor with IC50 s of 2.3 nM (FAK) and 120 nM(ALK cellular IC50 in 75% human plasma).
More description
|
![]() |
DC9649 | Cephalotaxlen Featured |
Cephalotaxine is an antiviral as well as antitumor agent.
More description
|
![]() |
DC22314 | Get73 Featured |
Get 73 has been investigated for the treatment of Alcohol Dependence.
More description
|
![]() |
DC7883 | GW791343 trihydrochloride Featured |
GW 791343 hydrochloride is a P2X7 allosteric modulator.
More description
|
![]() |
DC7428 | Inauhzin Featured |
Inauhzin(INZ) is a novel small molecule that effectively reactivates p53 by inhibiting SIRT1 activity, promotes p53-dependent apoptosis of human cancer cells without causing apparently genotoxic stress(IC50=3 uM, in A549 cell).
More description
|
![]() |
DC20239 | NDI-091143 Featured |
NDI-091143 is a novel ATP-citrate lyase inhibitor.
More description
|
![]() |
DC7866 | NMS-P715 Featured |
NMS-P715 is the first selective, ATP-competitive and orally bioavailable MPS1 small-molecule inhibitor(IC50=8 nM); selectively reduces cancer cell proliferation, leaving normal cells almost unaffected.
More description
|
![]() |
DC26134 | PROTAC ERRα ligand 2 Featured |
PROTAC ERRα ligand 2 is an estrogen-related receptor α (ERRα) inverse agonist with an IC50 of 5.67 nM. PROTAC ERRα ligand 2 (IC50=5.67 nM) displays a ~11-fold improved potency than XCT790 (IC50=61.3 nM)[1].
More description
|
![]() |
DC7380 | CGI-1746 Featured |
CGI1746 is a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation.
More description
|
![]() |
DC8728 | CH5424802(Alectinib HCl) Featured |
CH5424802(AF 802; Alectinib) is a potent ALK inhibitor with IC50 of 1.9 nM, sensitive to L1196M mutation.
More description
|
![]() |
DC23101 | Chelerythrine chloride Featured |
Chelerythrine is a potent, cell permeable inhibitor of protein kinase C (IC50 = 660 nM) that does not inhibit tyrosine protein kinases, cAMP-dependent protein kinase, or calcium/calmodulin-dependent protein kinase.
More description
|
![]() |
DC20266 | Chelerythrine Featured |
Chelerythrine is a well-known protein kinase C inhibitor, can inhibit telomerase activity, it also can block the human P2X 7 receptor.
More description
|
![]() |
DC10467 | CHMFL-BMX-078 Featured |
CHMFL-BMX-078 is a highly potent and selective type II irreversible BMX kinase inhibitor with an IC50 of 11 nM.
More description
|
![]() |
DC2088 | CI-1040 (PD184352) Featured |
CI-1040 (PD 184352) is an ATP non-competitive MEK1/2 inhibitor with IC50 of 17 nM.
More description
|
![]() |
DC9875 | Ciliobrevin A(HPI4) Featured |
Ciliobrevin A(HPI-4) is a Hedgehog pathway inhibitor and ciliogenesis inhibitor.
More description
|
![]() |
DC12369 | Cinaciguat (hydrochloride) Featured |
Cinaciguat is an activator of sGC that binds to a regulatory site, resulting in activation in an NO-independent manner (Kd = 3.2 nM).
More description
|
![]() |